Granahan Investment Management - ENTASIS THERAPEUTICS HLDGS I ownership

Quarter-by-quarter ownership
Granahan Investment Management ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q1 2021$22,000
-89.6%
10,064
-88.3%
0.00%
-100.0%
Q4 2020$212,000
-37.6%
85,654
-25.4%
0.01%
-58.3%
Q2 2020$340,000
-16.9%
114,829
-25.8%
0.01%
-45.5%
Q1 2020$409,000
-47.6%
154,658
-1.5%
0.02%
-38.9%
Q4 2019$780,000
-7.1%
156,944
+11.3%
0.04%
-21.7%
Q3 2019$840,000
-6.0%
141,012
+1.8%
0.05%
+4.5%
Q2 2019$894,000
-8.5%
138,541
-4.2%
0.04%
-15.4%
Q1 2019$977,000
+64.5%
144,583
-0.9%
0.05%
+23.8%
Q4 2018$594,000145,8440.04%
Other shareholders

There were no reported owners of ENTASIS THERAPEUTICS HLDGS I in Q3 2023.

NameSharesValueWeighting ↓
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders